Answers are grounded in this paper and cite their sources.
Background T H 17 cells have so far been considered to be crucial mediators of autoimmune inflammation. Two distinct types of T H 17 cells have been described recently, which differed in their polarization requirement for IL-1β and in their cytokine repertoire. Whether these distinct T H 17 phenotypes translate into distinct T H 17 cell functions with implications for human health or disease has not been addressed yet. Objective We hypothesized the existence of proinflammatory and anti-inflammatory human T H 17 cell functions based on the differential expression of IL-10, which is regulated by IL-1β. Considering the crucial role of IL-1β in the pathogenesis of autoinflammatory syndromes, we hypothesized that IL-1β mediates the loss of anti-inflammatory T H 17 cell functionalities in patients with Schnitzler syndrome, an autoinflammatory disease. Methods To assess proinflammatory versus anti-inflammatory T H 17 cell functions, we performed suppression assays and tested the effects of IL-1β dependent and independent T H 17 subsets on modulating proinflammatory cytokine secretion by monocytes. Patients with Schnitzler syndrome were analyzed for changes in T H 17 cell functions before and during therapy with IL-1β–blocking drugs. Results Both T H 17 cell subsets differ in their ability to suppress T-cell proliferation and their ability to modulate proinflammatory cytokine production by antigen-presenting cells because of their differential IL-10 expression properties. In patients with Schnitzler syndrome, systemic overproduction of IL-1β translates into a profound loss of anti-inflammatory T H 17 cell functionalities, which can be reversed by anti–IL-1β treatment. Conclusion IL-1β signaling determines the differential expression pattern of IL-10, which is necessary and sufficient to induce proinflammatory versus anti-inflammatory T H 17 cell functions. Our data introduce T H 17 cell subsets as novel players in autoinflammation and thus novel therapeutic targets in autoinflammatory syndromes including other IL-1β mediated diseases. This demonstrates for the first time alterations in the adaptive immune system in patients with autoinflammatory syndromes.
No takes yet. Share an insight, caveat, or question.
Noster et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: